BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 33673004)

  • 1. Natural Products and Nutrients against Different Viral Diseases: Prospects in Prevention and Treatment of SARS-CoV-2.
    Ali SG; Ansari MA; Alzohairy MA; Almatroudi A; Alomary MN; Alghamdi S; Rehman S; Khan HM
    Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33673004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plants and Natural Products with Activity against Various Types of Coronaviruses: A Review with Focus on SARS-CoV-2.
    Llivisaca-Contreras SA; Naranjo-Morán J; Pino-Acosta A; Pieters L; Vanden Berghe W; Manzano P; Vargas-Pérez J; León-Tamariz F; Cevallos-Cevallos JM
    Molecules; 2021 Jul; 26(13):. PubMed ID: 34279439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the Phytochemical Agents against the SARS-CoV and Some of them Selected for Application to COVID-19: A Mini-Review.
    Idrees M; Khan S; Memon NH; Zhang Z
    Curr Pharm Biotechnol; 2021; 22(4):444-450. PubMed ID: 32619167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection.
    Khare P; Sahu U; Pandey SC; Samant M
    Virus Res; 2020 Dec; 290():198169. PubMed ID: 32979476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Landscape of Natural Products against Coronaviruses: Perspectives in COVID-19 Treatment and Anti-viral Mechanism.
    Shawon J; Akter Z; Hossen MM; Akter Y; Sayeed A; Junaid M; Afrose SS; Khan MA
    Curr Pharm Des; 2020; 26(41):5241-5260. PubMed ID: 33155902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring algae and cyanobacteria as a promising natural source of antiviral drug against SARS-CoV-2.
    Sami N; Ahmad R; Fatma T
    Biomed J; 2021 Mar; 44(1):54-62. PubMed ID: 33640332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of natural compounds against the activity of SARS-CoV-2 NSP15 protein towards an effective treatment against COVID-19: a theoretical and computational biology approach.
    Motwalli O; Alazmi M
    J Mol Model; 2021 May; 27(6):160. PubMed ID: 33963942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioactive Terpenes and Their Derivatives as Potential SARS-CoV-2 Proteases Inhibitors from Molecular Modeling Studies.
    Diniz LRL; Perez-Castillo Y; Elshabrawy HA; Filho CDSMB; de Sousa DP
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33430299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351).
    Lee J; Lee J; Kim HJ; Ko M; Jee Y; Kim S
    Microbiol Spectr; 2021 Sep; 9(1):e0047221. PubMed ID: 34378968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural Substances and Semisynthetic Derivatives as Potential Alternative Products Against SARS-CoV-2.
    Fuochi V; Furneri PM
    Mini Rev Med Chem; 2021; 21(13):1596-1611. PubMed ID: 33535950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target-Specific Drug Discovery of Natural Products against SARS-CoV-2 Life Cycle and Cytokine Storm in COVID-19.
    Lee M; Park J; Cho IH
    Am J Chin Med; 2022; 50(4):927-959. PubMed ID: 35729089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broad-Spectrum Antiviral Agents Based on Multivalent Inhibitors of Viral Infectivity.
    Zelikin AN; Stellacci F
    Adv Healthc Mater; 2021 Mar; 10(6):e2001433. PubMed ID: 33491915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of Natural Products Inhibitors of SARS-CoV-2 Entry.
    González-Maldonado P; Alvarenga N; Burgos-Edwards A; Flores-Giubi ME; Barúa JE; Romero-Rodríguez MC; Soto-Rifo R; Valiente-Echeverría F; Langjahr P; Cantero-González G; Sotelo PH
    Molecules; 2022 Mar; 27(5):. PubMed ID: 35268843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Multiple Signal Transduction Pathways of SARS-CoV-2: Approaches to COVID-19 Therapeutic Candidates.
    Fakhri S; Nouri Z; Moradi SZ; Akkol EK; Piri S; Sobarzo-Sánchez E; Farzaei MH; Echeverría J
    Molecules; 2021 May; 26(10):. PubMed ID: 34068970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbial Natural Products with Antiviral Activities, Including Anti-SARS-CoV-2: A Review.
    Frediansyah A; Sofyantoro F; Alhumaid S; Al Mutair A; Albayat H; Altaweil HI; Al-Afghani HM; AlRamadhan AA; AlGhazal MR; Turkistani SA; Abuzaid AA; Rabaan AA
    Molecules; 2022 Jul; 27(13):. PubMed ID: 35807550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review on Screening Models for Potential Therapeutic Candidates and Targets Against SARS-CoV-2.
    Das M; Kumar M; Jha A; Madhukiran DR; Bharti K; Mondal S; Mishra B
    Curr Drug Targets; 2021; 22(11):1232-1254. PubMed ID: 33371846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. West African medicinal plants and their constituent compounds as treatments for viral infections, including SARS-CoV-2/COVID-19.
    Popoola TD; Segun PA; Ekuadzi E; Dickson RA; Awotona OR; Nahar L; Sarker SD; Fatokun AA
    Daru; 2022 Jun; 30(1):191-210. PubMed ID: 35476297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural Products Homoharringtonine and Emetine Alkaloids as SARS-CoV-2 Treatment Options.
    Sohrab SS; Suhail M; Kamal MA; Azhar EI
    Curr Pharm Des; 2021; 27(32):3444-3453. PubMed ID: 33302852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric Oxide to Fight Viral Infections.
    Lisi F; Zelikin AN; Chandrawati R
    Adv Sci (Weinh); 2021 Apr; 8(7):2003895. PubMed ID: 33850691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promising natural products against SARS-CoV-2: Structure, function, and clinical trials.
    Zhao Y; Deng S; Bai Y; Guo J; Kai G; Huang X; Jia X
    Phytother Res; 2022 Oct; 36(10):3833-3858. PubMed ID: 35932157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.